Sino Biopharmaceutical Limited SBMFF
Set alert
0.67 USD 0.00 0.00%
At close · Oct 30
0.6509 Day range 0.6509
0.593 52-week range 0.891
- YTD
- -23.74%
- 1 year
- -22.85%
- Open
- 0.6509
- Prev close
- 0.665
- Mkt cap
- 11.83B
- Vol
- 1.00K
- Avg vol
- 647
- EPS
- 0.02
- P/E
- 33.25
More statistics
- Low
- 0.6509
- High
- 0.6509
- Earnings
- Aug 26, 2026
2Y chart
Events in this range
- Dec 31, 2024Earnings: 0.00182; estimate —; surprise —%
- Mar 20, 2025Earnings: 0.00411; estimate 0.01096; surprise -62.5%
- Jun 16, 2025Dividend: 0.0051
- Jun 18, 2025Dividend: 0.0051
- Aug 18, 2025Earnings: 0.02624; estimate 0.01675; surprise 56.66%
- Aug 29, 2025Dividend: 0.006397
- Sep 2, 2025Dividend: 0.0064
- Mar 26, 2026Earnings: 0.00143; estimate 0.00858; surprise -83.33%
- Mar 26, 2026Earnings: 0.00143; estimate 0.00858; surprise -83.33%
- Jun 24, 2026Dividend: 0.0063755
- Jun 26, 2026Dividend: 0.0064
- Aug 26, 2026Earnings: —; estimate 0.01766; surprise —%
- Sep 1, 2026Dividend: 0.009
- Sep 3, 2026Dividend: 0.07
Signals (46)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 19, 2026 | 1 week ago |
| RSI: Oversold | Oct 19, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 5, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 5, 2026 | 2 months ago |
| RSI: Oversold | Aug 5, 2026 | 2 months ago |
| MACD: Buy Signal | Jun 25, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 23, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 10, 2026 | 4 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| MACD: Buy Signal | May 20, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 14, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 25, 2026 | 7 months ago |
| RSI: Oversold | Mar 25, 2026 | 7 months ago |
| MACD: Buy Signal | Feb 17, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| RSI: Oversold | Feb 2, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| RSI: Oversold | Oct 9, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 19, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 8, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 17, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 1, 2025 | 1 year ago |
| RSI: Overbought | Jun 23, 2025 | 1 year ago |
| MACD: Buy Signal | May 27, 2025 | 1 year ago |
| MACD: Sell Signal | May 5, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 15, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 9, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 24, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 14, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 18, 2025 | 1 year ago |
| RSI: Overbought | Feb 18, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 30, 2025 | 1 year ago |
| RSI: Oversold | Jan 30, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 3, 2025 | 1 year ago |
| MACD: Sell Signal | Dec 19, 2024 | 1 year ago |
Next earnings
Aug 26, 2026
Expected Aug 26, 2026. Consensus EPS estimate 0.01766.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jun 30, 2026 | 0.01766 | — | — | — |
| Mar 26, 2026 | Mar 31, 2026 | 0.00858 | 0.00143 | -0.01 | -83.33% |
| Mar 26, 2026 | Dec 31, 2025 | 0.00858 | 0.00143 | -0.01 | -83.33% |
| Aug 18, 2025 | Jun 30, 2025 | 0.01675 | 0.02624 | +0.01 | +56.66% |
| Mar 20, 2025 | Mar 31, 2025 | 0.01096 | 0.00411 | -0.01 | -62.50% |
| Dec 31, 2024 | Dec 31, 2024 | — | 0.00182 | — | — |
News
- Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs
- AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
- Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion
- Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln
- Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea
Your note
Sign in to keep a note on SBMFF — it syncs with the Stock Master app.